Local kappa opioid receptor activation decreases temporomandibular joint inflammation

Inflammation

Volumn 35, Issue 1, 2012, Pages 371-376

  Chicre Alcântara, Tânia C ^a,b   Torres Chávez, Karla E ^a   Fischer, Luana ^c   Clemente Napimoga, JulianaT ^a   Melo, Vilma ^a,b   Parada, Carlos Amílcar ^a   Tambeli, Claudia Herrera ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b Universidade da Amazonia   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Inflammation; Kappa opioid receptors; Temporomandibular joint

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE; KAPPA OPIATE RECEPTOR; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; EXTRAVASATION; LEUKOCYTE MIGRATION; MALE; NEUTROPHIL; NONHUMAN; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; RAT; TEMPOROMANDIBULAR JOINT DISORDER;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; FORMALDEHYDE; INFLAMMATION; MALE; NALTREXONE; NEUTROPHIL INFILTRATION; NEUTROPHILS; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; TEMPOROMANDIBULAR JOINT;

EID: 84859429713     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-011-9329-1     Document Type: Article

References (21)

1. Tambeli, C.H., L. Fischer, and C.A. Parada. 2009. Chapter 14: Opioid receptors. In Peripheral receptor targets for analgesia, ed. B. Cairns, 347-72. Wiley: New York.
2. Alstergren, P., and S. Kopp. 2000. Prostaglandin E2 in temporomandibular joint synovial fluid and its relation to pain and inflammatory disorders. J Oral Maxillofac Surg 58: 180-6. Discussion, 6-8.
3. Suzuki, T., N. Segami, M. Nishimura, J. Sato, and T. Nojima. 2003. Bradykinin expression in synovial tissues and synovial fluids obtained from patients with internal derangement of the temporomandibular joint. Cranio 21: 265-70. (Pubitemid 38859701)
4. Stein, A., A. Yassouridis, C. Szopko, K. Helmke, and C. Stein. 1999. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 83: 525-32.
5. Stein, C. 2006. Intra-articular morphine for inflammatory pain. Reg Anesth Pain Med 31: 496-7. (Pubitemid 44810081)
6. Ziegler, C.M., J. Wiechnik, and J. Muhling. 2010. Analgesic effects of intra-articular morphine in patients with temporomandibular joint disorders: A prospective, double-blind, placebo-controlled clinical trial. J Oral Maxillofac Surg 68: 622-7.
7. Eisenach, J.C., R. Carpenter, and R. Curry. 2003. Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis. Pain 101: 89-95. (Pubitemid 36044656)
8. Gaveriaux-Ruff, C., L.A. Karchewski, X. Hever, A. Matifas, and B.L. Kieffer. 2008. Inflammatory pain is enhanced in delta opioid receptor-knockout mice. Eur J Neurosci 27: 2558-67. (Pubitemid 351781665)
9. Alebouyeh, M., Z. Pourpak, and A. Ahmadiani. 2002. Increase in serum level of interleukin-1 alpha mediates morphine antiinflammatory effect in carrageenan-induced paw oedema in mice. Cytokine 19: 102-5.
10. Jimenez, N., M.M. Puig, and O. Pol. 2006. Antiexudative effects of opioids and expression of kappa- and delta-opioid receptors during intestinal inflammation in mice: involvement of nitric oxide. J Pharmacol Exp Ther 316: 261-70. (Pubitemid 41832605)
11. Green, P.G., and J.D. Levine. 1992. Delta- and kappa-opioid agonists inhibit plasma extravasation induced by bradykinin in the knee joint of the rat. Neuroscience 49: 129-33.
12. Bastos JV, Queiroz-Junior CM, Caliari MV, Francischi JN, Pacheco CM, Maltos KL. 2011. Peripheral kappa opioid receptors activation reduces alveolar bone loss in rats by modulating interleukin-6 and -10. Arch Oral Biol (in press).
13. Kulkarni-Narla, A., B. Walcheck, and D.R. Brown. 2001. Opioid receptors on bone marrow neutrophils modulate chemotaxis and CD11b/CD18 expression. Eur J Pharmacol 414: 289-94. (Pubitemid 32181897)
14. Qu, Z.X., J. Xu, E.L. Hogan, and C.Y. Hsu. 1993. Effect of U- 50488h, a selective opioid kappa receptor agonist, on vascular injury after spinal cord trauma. Brain Res 626: 45-9. (Pubitemid 23306810)
15. Clemente, J.T., C.A. Parada, M.C. Veiga, R.W. Gear, and C.H. Tambeli. 2004. Sexual dimorphism in the antinociception mediated by kappa opioid receptors in the rat temporomandibular joint. Neurosci Lett 372: 250-5. (Pubitemid 39470206)
16. Zimmermann, M. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-10. (Pubitemid 13058546)
17. Haas, D.A., O. Nakanishi, R.E. MacMillan, R.C. Jordan, and J.W. Hu. 1992. Development of an orofacial model of acute inflammation in the rat. Arch Oral Biol 37: 417-22.
18. Heinecke, J.W. 1999. Mechanisms of oxidative damage by myeloperoxidase in atherosclerosis and other inflammatory disorders. J Lab Clin Med 133: 321-5. (Pubitemid 29373028)
19. Bradley, P.P., D.A. Priebat, R.D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Investig Dermatol 78: 206-9. (Pubitemid 12171880)
20. Clemente-Napimoga, J.T., A. Pellegrini-da-Silva, V.H. Ferreira, M. H. Napimoga, C.A. Parada, and C.H. Tambeli. 2009. Gonadal hormones decrease temporomandibular joint kappa-mediated antinociception through a down-regulation in the expression of kappa opioid receptors in the trigeminal ganglia. Eur J Pharmacol 617: 41-7.
21. Binder, W., and J.S. Walker. 1998. Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis. Br J Pharmacol 124: 647-54. (Pubitemid 28276800)